SCHEMBL12813268

SCHEMBL12813268

COc1ccc2c(c1)[C@]1(C)CCCC(C)(C)[C@@H]1[C@H]2O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ POLA1 P09884 4/20 0.44
▸ EHMT2 Q96KQ7 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ PDE7A Q13946 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ OPRM1 P35372 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ADRB2 P07550 1/20 0.35
▸ HTR1A P08908 1/20 0.35
▸ ADRA2A P08913 1/20 0.35
▸ ADRA2B P18089 1/20 0.35
▸ SLC6A2 P23975 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12821663 0.89 CYP3A4 (0.42) CYP3A4CYP2C9TSHRCYP2C19POLA1
SCHEMBL16499505 0.89 CYP3A4 (0.42) CYP3A4CYP2C9TSHRCYP2C19POLA1
SCHEMBL12821627 0.85 SLC6A4 (0.37) CYP3A4CYP2C9TSHRCYP2C19SLC6A3
SCHEMBL16499376 0.85 SLC6A4 (0.37) CYP3A4CYP2C9TSHRCYP2C19SLC6A3
SCHEMBL16499264 0.82 TRPA1 (0.35) CYP3A4MAPK1MEN1KMT2A
SCHEMBL12825623 0.82 TRPA1 (0.35) CYP3A4MAPK1MEN1KMT2A
SCHEMBL12813322 0.81 CYP19A1 (0.36) ALDH1A1PDE7ALMNAKMT2ASLC6A3
SCHEMBL16499567 0.81 TRPA1 (0.39) SIGMAR1
SCHEMBL12813600 0.81 CYP19A1 (0.36) ALDH1A1PDE7ALMNAKMT2ASLC6A3
SCHEMBL16499383 0.81 TRPA1 (0.39) SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012134971-A2 OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE BIKAM PHARMACEUTICALS, INC. (US) 2012-10-04 — — WO disclosed
Send feedback